Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Phase 1 Recruiting
40 enrolled
PROPS GYN
Phase 2 Recruiting
25 enrolled
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Phase 4 Recruiting
100 enrolled
DE-01
Phase 3 Recruiting
600 enrolled
(TRUS)
Recruiting
17 enrolled
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Phase 3 Recruiting
700 enrolled
RAINFOL-01
Phase 1/2 Recruiting
764 enrolled
Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Phase 2 Recruiting
25 enrolled
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
Phase NA Recruiting
60 enrolled
OPTICS
Phase NA Recruiting
10,000 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
Image-Guided Gynecologic Brachytherapy
Phase NA Recruiting
54 enrolled
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Phase 1 Recruiting
36 enrolled
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Phase 1 Recruiting
49 enrolled
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
Phase 1/2 Recruiting
54 enrolled
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Phase 2 Recruiting
32 enrolled
Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery
Phase NA Recruiting
50 enrolled
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
Recruiting
1,000 enrolled
OvAR-Y
Recruiting
10 enrolled
PROACTION:
Recruiting
4,500 enrolled
MySaturn
Recruiting
111 enrolled
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Phase 1 Recruiting
30 enrolled
BARHYSTER
Recruiting
132 enrolled
[18F]FES PET/.CT in Uterine Cancer
Phase 2 Recruiting
30 enrolled
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Phase 1/2 Recruiting
37 enrolled
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Phase NA Recruiting
192 enrolled
Study of NEO-201 in Solid Tumors Expansion Cohorts
Phase 1/2 Recruiting
121 enrolled